Across
- 3. 8 week double blind period.
- 6. All data must be entered into the CRF within how many calendar days of assessments being completed.
- 7. Required and should be completed for each included subject.
- 8. Investigator portal for the Vibrato Study.
Down
- 1. A useful tool to assist your site to prepare for subject visits.
- 2. Subjects in this treatment period will not receive the placebo in PA5.
- 4. Provides central laboratory services
- 5. Primary Objective at Week 8 for evaluation of PF-06651600 and PF-06700841.
